Myeloid Dendritic Cell-Specific mTORC2 Deficiency Enhances Alloreactive Th1 and Th17 Cell Responses and Skin Graft Rejection

Authors :: Dàlia Raïch-Regué
Angus W. Thomson
Brian R. Rosborough
Heth R. Turnquist
Source :: Transplantation. 98:18-19
Publication Year :: 2014
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2014.

Subjects :: Transplantation
medicine.anatomical_structure
Graft rejection
business.industry
Myeloid Dendritic Cell
Cell
Cancer research
medicine
business
mTORC2

Tools